...
机译:新颖,弱溴和额外末端域(BET)溴域片段配体的优化至有效和选择性的第二溴琼瓜(BD2)抑制剂
GlaxoSmithKline Epigenet Discovery Performance Unit Med Res Ctr Stevenage SG1 2NY Herts England;
GlaxoSmithKline Epigenet Discovery Performance Unit Med Res Ctr Stevenage SG1 2NY Herts England;
GlaxoSmithKline Epigenet Discovery Performance Unit Med Res Ctr Stevenage SG1 2NY Herts England;
GlaxoSmithKline Med Res Ctr Platform Technol &
Sci Stevenage SG1 2NY Herts England;
GlaxoSmithKline Med Res Ctr Platform Technol &
Sci Stevenage SG1 2NY Herts England;
GlaxoSmithKline Med Res Ctr Platform Technol &
Sci Stevenage SG1 2NY Herts England;
GlaxoSmithKline Med Res Ctr Platform Technol &
Sci Stevenage SG1 2NY Herts England;
GlaxoSmithKline IVIVT Cellzome Platform Technol &
Sci D-69117 Heidelberg Germany;
GlaxoSmithKline Med Res Ctr Quantitat Pharmacol &
Immunoinflammat Therapy Are Stevenage SG1 2NY Herts England;
GlaxoSmithKline Epigenet Discovery Performance Unit Med Res Ctr Stevenage SG1 2NY Herts England;
GlaxoSmithKline Epigenet Discovery Performance Unit Med Res Ctr Stevenage SG1 2NY Herts England;
GlaxoSmithKline Epigenet Discovery Performance Unit Med Res Ctr Stevenage SG1 2NY Herts England;
GlaxoSmithKline Med Res Ctr Platform Technol &
Sci Stevenage SG1 2NY Herts England;
GlaxoSmithKline IVIVT Cellzome Platform Technol &
Sci D-69117 Heidelberg Germany;
GlaxoSmithKline Epigenet Discovery Performance Unit Med Res Ctr Stevenage SG1 2NY Herts England;
GlaxoSmithKline Epigenet Discovery Performance Unit Med Res Ctr Stevenage SG1 2NY Herts England;
GlaxoSmithKline Epigenet Discovery Performance Unit Med Res Ctr Stevenage SG1 2NY Herts England;
GlaxoSmithKline Epigenet Discovery Performance Unit Med Res Ctr Stevenage SG1 2NY Herts England;
GlaxoSmithKline IVIVT Cellzome Platform Technol &
Sci D-69117 Heidelberg Germany;
GlaxoSmithKline Med Res Ctr Platform Technol &
Sci Stevenage SG1 2NY Herts England;
GlaxoSmithKline Epigenet Discovery Performance Unit Med Res Ctr Stevenage SG1 2NY Herts England;
GlaxoSmithKline Med Res Ctr Platform Technol &
Sci Stevenage SG1 2NY Herts England;
GlaxoSmithKline Epigenet Discovery Performance Unit Med Res Ctr Stevenage SG1 2NY Herts England;
机译:新颖,弱溴和额外末端域(BET)溴域片段配体的优化至有效和选择性的第二溴琼瓜(BD2)抑制剂
机译:模板跳跃方法导致有效,选择性和高度可溶性的溴和果实结构域(BET)第二溴呢素(BD2)抑制剂
机译:发现8-甲基-Pyrrolo [1,2-a]吡嗪-1(2h) - 衍生物,衍生物是高效和选择性的溴琼瘤和外终端(BET)溴染色剂抑制剂
机译:溴和额外末端的溴莫蛋白的多种结构聚类(BET)蛋白质突出了其结构动力学和乙酰化亮氨酸粘合口袋的微妙差异
机译:基于结构的配体设计的计算方法:P / CAF Bromodomain配体的图解
机译:GSK973是第二溴染色瘤的抑制剂(BD2S)溴莫州和额外的终端(赌注)家庭
机译:新颖,弱溴和额外末端域(BET)溴域片段配体的优化至有效和选择性的第二溴琼瓜(BD2)抑制剂